Affinage

TFB2M

Dimethyladenosine transferase 2, mitochondrial · UniProt Q9H5Q4

Length
396 aa
Mass
45.3 kDa
Annotated
2026-06-10
13 papers in source corpus 11 papers cited in narrative 11 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

TFB2M is an essential mitochondrial transcription initiation factor that, with TFAM and the mitochondrial RNA polymerase POLRMT, drives synthesis from the LSP and HSP1 promoters of mtDNA, increasing transcription efficiency 100–200-fold over polymerase alone; its paralog TFB1M is transcriptionally inactive in this role (PMID:20410300). Within the initiation complex, TFB2M acts after promoter recruitment to enable promoter melting and productive RNA synthesis—POLRMT plus TFB2M can generate short abortive RNAs on LSP, but full open-complex formation and longer transcripts require all three factors (PMID:27903899). TFB2M contacts the non-template strand of the transcription bubble, recognizing the conserved (−1)AAA(+2) sequence through residue Y209 and a non-template stabilizing loop to stabilize the melted promoter, and is released in an ordered fashion during the transition to the elongation complex prior to TEFM recruitment [PMID:bio_10.1101_2024.12.02.626445, PMID:bio_10.1101_2025.04.03.647028]. Its DNA-binding activity is autoinhibited by a flexible C-terminal tail that engages the DNA-binding groove intramolecularly, an autoinhibition relieved upon POLRMT binding (PMID:32241911). TFB2M is indispensable for mtDNA maintenance: genetic knockout in human cybrid cells causes complete mtDNA loss and abolishes priming of both strand-asynchronous and strand-coupled replication, a defect that TFB1M cannot rescue (PMID:34744028). Its own expression is governed by the NRF-1/NRF-2 and PGC-1α coactivator program of mitochondrial biogenesis (PMID:15684387).

Mechanistic history

Synthesis pass · year-by-year structured walk · 9 steps
  1. 2005 Medium

    Established how TFB2M expression is wired into the mitochondrial biogenesis program, placing it downstream of the nuclear respiratory factor/PGC-1α network rather than being constitutively expressed.

    Evidence Promoter-reporter transactivation with NRF-1/NRF-2 site mutations and PGC-1α overexpression in cell systems

    PMID:15684387

    Open questions at the time
    • Does not address TFB2M's biochemical activity
    • Cell-system overexpression may not reflect endogenous regulation
  2. 2010 High

    Resolved which paralog is the genuine mitochondrial transcription factor, showing TFB2M—not TFB1M—synergizes with TFAM to activate the LSP and HSP1 promoters.

    Evidence Fully reconstituted in vitro transcription with purified recombinant components and paralog comparison

    PMID:20410300

    Open questions at the time
    • Did not define the molecular step TFB2M acts at within initiation
    • No structural basis for promoter recognition
  3. 2010 Medium

    Raised the possibility of a non-mitochondrial role by detecting nuclear TFB2M binding and regulating the Serca2 promoter, extending its function beyond mtDNA.

    Evidence Immunostaining, ChIP, fluorescence correlation spectroscopy, and promoter mutagenesis in rat cardiac myocytes with overexpression

    PMID:21113058

    Open questions at the time
    • Relies on overexpression in a single cell type
    • Endogenous nuclear function not confirmed
    • No reciprocal validation of the DNA contact
  4. 2016 High

    Defined TFB2M's mechanistic step as post-recruitment, showing it is needed together with TFAM and POLRMT to melt the LSP and extend RNA beyond abortive products.

    Evidence 2-aminopurine melting maps, fluorescence anisotropy binding, and abortive RNA synthesis assays in vitro

    PMID:27903899

    Open questions at the time
    • Atomic-level contacts of TFB2M with the bubble not resolved
    • Tested only on LSP for some assays
  5. 2020 High

    Explained how TFB2M DNA binding is gated, identifying an autoinhibitory C-terminal tail relieved by POLRMT to license promoter engagement.

    Evidence Fluorescence anisotropy DNA-binding titrations with C-tail deletion mutants and crystal-structure analysis

    PMID:32241911

    Open questions at the time
    • Structural detail of the tail–groove interaction within an intact complex not resolved
    • Kinetics of autoinhibition relief not measured
  6. 2021 High

    Demonstrated that TFB2M is strictly required for mtDNA maintenance and replication priming, with its loss causing complete mtDNA depletion that TFB1M cannot rescue.

    Evidence CRISPR/genetic knockout in human cybrid cells with 2D agarose gel analysis of replication intermediates and copy-number quantification

    PMID:34744028

    Open questions at the time
    • Mechanistic link between transcription and replication priming not biochemically dissected
    • Does not separate transcription from priming functions
  7. 2025 Medium

    Provided the structural basis for promoter melting and ordered factor release, showing TFB2M contacts the −1 non-template adenine via Y209 and a stabilizing loop and disengages before elongation.

    Evidence Cryo-EM structures of human initiation and transition complexes (preprint)

    PMID:bio_10.1101_2024.12.02.626445 PMID:bio_10.1101_2025.04.03.647028

    Open questions at the time
    • Preprint, not peer-reviewed
    • Single lab
    • Timing/triggers of TFB2M release relative to TEFM recruitment not kinetically defined
  8. 2018 Medium

    Linked a TFB2M coding variant to altered mitochondrial output, suggesting hinge-region rigidity changes TFB2M loading/unloading on DNA.

    Evidence Overexpression of His264Tyr vs wild-type in fibroblasts with mitochondrial function readouts and molecular dynamics simulation

    PMID:30414672

    Open questions at the time
    • Structural inference is simulation-based
    • Disease causality not established by genetics alone
    • Overexpression context
  9. 2025 Low

    Implicated TFB2M levels in cancer cell metabolism and survival, but through downstream/cellular pathways rather than its core transcriptional mechanism.

    Evidence siRNA/overexpression in HCC and lung adenocarcinoma cells with metabolic and ferroptosis/mitophagy readouts and xenograft models

    PMID:33982328 PMID:40878482

    Open questions at the time
    • Mechanism linking TFB2M to mitophagy initiation not directly established
    • Pathway connections inferred, not reconstituted
    • Single labs

Open questions

Synthesis pass · forward-looking unresolved questions
  • How TFB2M release is precisely triggered and coordinated with TEFM hand-off, and whether its reported nuclear/non-mitochondrial functions occur endogenously, remain open.
  • No kinetic model of TFB2M release coupled to elongation
  • Endogenous nuclear function unconfirmed
  • Mechanistic separation of transcription vs replication-priming roles

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0003677 DNA binding 3 GO:0140097 catalytic activity, acting on DNA 2 GO:0140110 transcription regulator activity 2
Localization
GO:0005739 mitochondrion 2 GO:0005634 nucleus 1
Pathway
R-HSA-74160 Gene expression (Transcription) 2 R-HSA-69306 DNA Replication 1
Partners
POLRMTTEFMTFAM
Complex memberships
mitochondrial transcription initiation complex

Evidence

Reading pass · 11 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2010 In a reconstituted in vitro transcription system, TFAM and TFB2M act synergistically to increase mitochondrial transcription efficiency 100–200-fold compared with RNA polymerase alone; TFB1M (the paralog) showed no significant transcription activity, establishing TFB2M—not TFB1M—as the bona fide mitochondrial transcription factor. Only two promoters, LSP and HSP1, were found to be functional in this system. Recombinant in vitro transcription reconstitution with purified components; promoter template assays The Journal of biological chemistry High 20410300
2016 TFAM has post-recruitment roles in promoter melting and RNA synthesis beyond simply recruiting POLRMT and TFB2M. 2-aminopurine mapping showed the LSP is melted from −4 to +1 in the open complex with all three proteins; POLRMT+TFB2M alone can make 2-mer abortive RNAs on LSP but longer RNAs require TFAM. Two-component complexes of POLRMT with either TFB2M or TFAM form stable low-nanomolar Kd complexes on LSP but cannot efficiently melt the promoter without the third factor. 2-aminopurine fluorescence mapping of promoter melting; equilibrium fluorescence anisotropy binding assays; in vitro abortive RNA synthesis assays Nucleic acids research High 27903899
2020 The flexible C-terminal tail (C-tail) of TFB2M functions as an autoinhibitory element that suppresses DNA binding by engaging intramolecularly with the DNA binding groove. Deletion of the C-tail greatly increases TFB2M's DNA binding affinity. RNA polymerase (POLRMT) relieves this autoinhibition by interacting with the C-tail and engaging it in complex formation. Fluorescence anisotropy-based quantitative DNA binding titrations with C-tail deletion mutants; structural analysis of available TFB2M crystal structures The Journal of biological chemistry High 32241911
2005 Expression of TFB2M (and TFB1M) is transcriptionally governed by nuclear respiratory factors NRF-1 and NRF-2; NRF recognition sites within the TFB2M promoter are required for maximal transactivation by PGC-1α and PRC coactivators. Ectopic PGC-1α expression is sufficient to induce coordinate expression of TFB2M along with TFAM and nuclear/mitochondrial respiratory subunits. Promoter-reporter transactivation assays with NRF-1/NRF-2 binding site mutations; ectopic PGC-1α overexpression in cell systems; mRNA quantification during mitochondrial biogenesis induction Molecular and cellular biology Medium 15684387
2010 TFB2M localizes to the nucleus (in addition to mitochondria) in rat neonatal cardiac myocytes and directly binds to the −122 to −117 nt region of the rat Serca2 gene promoter. Mutation of this binding site decreased Serca2 gene transcription, demonstrating a nuclear transcription function for TFB2M at a non-mitochondrial gene. Immunostaining for nuclear localization; chromatin immunoprecipitation (ChIP) assay; fluorescence correlation spectroscopy; promoter mutation/reporter assays; overexpression in cardiac myocytes Cardiovascular research Medium 21113058
2021 Knockout of TFB2M in human cybrid cells results in complete mtDNA loss, demonstrating that TFB2M is indispensable for maintenance of human mtDNA. The loss of TFB2M could not be compensated by TFB1M, establishing TFB2M as essential for priming of both strand-asynchronous and strand-coupled mtDNA replication. CRISPR/genetic knockout of TFB2M in human cybrid cells; two-dimensional agarose gel electrophoresis of replication intermediates; mtDNA copy number quantification Biochimica et biophysica acta. Molecular cell research High 34744028
2025 Cryo-EM structures of human mitochondrial transcription initiation complexes (IC3 and slipped-IC3) reveal that TFB2M contacts the −1 non-template adenine to stabilize the transcription bubble, and that TFB2M residues Y209 and the non-template stabilizing loop (K153LDPRSGGVIKPP165) recognize the conserved non-template sequence (−1)AAA(+2). The structures also show sequential release of TFB2M during the transition from initiation to elongation complex. Cryo-EM structure determination of active initiation complexes with resolved transcription bubbles and RNA transcripts bioRxivpreprint Medium bio_10.1101_2024.12.02.626445
2025 A series of cryo-EM structures capturing the mitochondrial transcription complex transitioning from the open promoter complex to the processive elongation complex reveal new determinants of promoter specificity, sequential disengagement of mtRNAP from TFAM and the promoter, and the ordered release of TFB2M prior to recruitment of elongation factor TEFM. Cryo-EM structures of multiple intermediate transcription complexes bioRxivpreprint Medium bio_10.1101_2025.04.03.647028
2018 A homozygous c.790C>T (His264Tyr) variant in TFB2M found in ASD patients causes increased mitochondrial gene transcription and enhanced mitochondrial function (ATP, membrane potential, oxygen consumption, ROS) when overexpressed in fibroblasts compared with wild-type TFB2M. Molecular dynamics simulation suggested increased rigidity of the hinge region, potentially altering TFB2M loading/unloading on DNA. Overexpression of variant vs. wild-type TFB2M in primary fibroblasts; quantification of mitochondrial function parameters; molecular dynamics simulation Biochemical and biophysical research communications Medium 30414672
2021 TFB2M overexpression in HCC cells enhances reprogramming of glucose metabolism from oxidative phosphorylation to aerobic glycolysis by upregulating glycolytic genes (GAPDH, LDHA, GLUT1, HK2) and downregulating PGC-1α, acting through NAD+/SIRT3/HIF-1α signaling. Cell glucose metabolism assays; metabolomics; siRNA knockdown and overexpression of TFB2M; measurement of NAD+, SIRT3, HIF-1α levels in HCC cells Journal of gastroenterology and hepatology Low 33982328
2025 Knockdown of TFB2M in lung adenocarcinoma cells induces ferroptosis through a mitophagy-dependent mechanism: TFB2M knockdown promotes mitophagy, which leads to GPX4 degradation (co-localization of GPX4 with mitochondrial outer membrane protein TOMM20 observed by immunofluorescence), increased lipid peroxidation markers, and ferroptotic cell death. This phenotype was reversed by the mitophagy inhibitor Mdivi-1. siRNA knockdown of TFB2M; western blot for ferroptosis/mitophagy markers; immunofluorescence co-localization; ferroptosis metabolite measurements (MDA, GSH, 4-HNE, ROS, Fe2+); xenograft mouse model with Mdivi-1 treatment Expert review of anticancer therapy Low 40878482

Source papers

Stage 0 corpus · 13 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2005 Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators. Molecular and cellular biology 557 15684387
2010 Human mitochondrial transcription revisited: only TFAM and TFB2M are required for transcription of the mitochondrial genes in vitro. The Journal of biological chemistry 162 20410300
2016 Human mitochondrial transcription factors TFAM and TFB2M work synergistically in promoter melting during transcription initiation. Nucleic acids research 72 27903899
2010 Mitochondrial transcription factors TFAM and TFB2M regulate Serca2 gene transcription. Cardiovascular research 47 21113058
2010 Mitochondrial DNA depletion and its correlation with TFAM, TFB1M, TFB2M and POLG in human diffusely infiltrating astrocytomas. Mitochondrion 42 20643228
2020 Over-expression of TFB2M facilitates cell growth and metastasis via activating ROS-Akt-NF-κB signalling in hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 23 32174027
2021 TFB2M and POLRMT are essential for mammalian mitochondrial DNA replication. Biochimica et biophysica acta. Molecular cell research 19 34744028
2021 TFB2M activates aerobic glycolysis in hepatocellular carcinoma cells through the NAD+ /SIRT3/HIF-1α signaling. Journal of gastroenterology and hepatology 13 33982328
2023 Expression and Purification of Recombinant Human Mitochondrial RNA Polymerase (POLRMT) and the Initiation Factors TFAM and TFB2M. Bio-protocol 8 38094251
2020 The C-terminal tails of the mitochondrial transcription factors Mtf1 and TFB2M are part of an autoinhibitory mechanism that regulates DNA binding. The Journal of biological chemistry 8 32241911
2018 Identification of a rare homozygous c.790C>T variation in the TFB2M gene in Korean patients with autism spectrum disorder. Biochemical and biophysical research communications 8 30414672
2008 Mutational screening of the mitochondrial transcription factors B1 and B2 (TFB1M and TFB2M) in Parkinson's disease. Parkinsonism & related disorders 5 18980857
2025 Knockdown of TFB2M induces ferroptosis in lung adenocarcinoma via mitophagy-mediated GPX4 degradation. Expert review of anticancer therapy 0 40878482

Missed literature

Know a paper Affinage missed for TFB2M? Flag it for the maintainers and the community.

No submissions yet.